A new hope to fight against Alzheimer’s disease, which is from a phase 2 clinical trial show that the medication, an antibody called BAN2401, slowed the progression of the disease and increased cognitive performance. BAN2401 is produced by the Biogen and Eisai presented details about the clinical trial in July 25, 2018, at the Alzheimer’s ...

FDA has approved clinical trials in Samford health for its institution second ever adipose-derived stem cell clinical trial which is designed to treat non-healing leg ulcers. The trial has started in September of this year. The trial includes the study participants with an age above 18 with a leg wound 3- 25 cm and with ...